Margareta T. Wilhelm

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model.

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model.

Journal: Molecular oncology

Published: November 12, 2025

TGF-α/EGFR-mediated lymphatic metastasis reveals a repositionable therapeutic target in breast cancer.

TGF-α/EGFR-mediated lymphatic metastasis reveals a repositionable therapeutic target in breast cancer.

Journal: NPJ breast cancer

Published: September 14, 2025

EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity.

EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity.

Journal: Oncoimmunology

Published: April 07, 2025

Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing.

Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing.

Journal: Neuro-oncology

Published: October 09, 2024

High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in sonic hedgehog-medulloblastoma.

High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in sonic hedgehog-medulloblastoma.

Journal: Neuro-oncology

Published: June 11, 2024

The Tumor Microenvironment of Medulloblastoma: An Intricate Multicellular Network with Therapeutic Potential.

The Tumor Microenvironment of Medulloblastoma: An Intricate Multicellular Network with Therapeutic Potential.

Journal: Cancers

Published: August 25, 2022

p73 is required for vessel integrity controlling endothelial junctional dynamics through Angiomotin.

p73 is required for vessel integrity controlling endothelial junctional dynamics through Angiomotin.

Journal: Cellular and molecular life sciences : CMLS

Published: June 11, 2022

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule.

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule.

Journal: Frontiers in molecular biosciences

Published: November 29, 2021

High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice.

High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice.

Journal: Cancers

Published: October 02, 2021

TAp73 represses NF-κB-mediated recruitment of tumor-associated macrophages in breast cancer.

TAp73 represses NF-κB-mediated recruitment of tumor-associated macrophages in breast cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 02, 2021

Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells.

Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 05, 2020

p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids.

p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids.

Journal: Cell death & disease

Published: May 23, 2019

Showing 1-12 of 22

Last Updated: 09/26/2026